Literature DB >> 26847679

Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.

Mitsuro Kanda1, Akira Mizuno2, Tsutomu Fujii2, Yoshie Shimoyama3, Suguru Yamada2, Chie Tanaka2, Daisuke Kobayashi2, Masahiko Koike2, Naoki Iwata2, Yukiko Niwa2, Masamichi Hayashi2, Hideki Takami2, Goro Nakayama2, Hiroyuki Sugimoto2, Michitaka Fujiwara2, Yasuhiro Kodera2.   

Abstract

BACKGROUND: In East Asia, the tumor infiltrative pattern (INF) has been routinely evaluated by hematoxylin and eosin-stained sections as a pathologic characteristic of surgically resected specimens.
METHODS: The infiltrative pattern of gastric cancer (GC) has been histopathologically classified as INFa (expansive growth), INFb (intermediate type) and INFc (infiltrative growth) according to the Japanese Classification of Gastric Carcinoma. The prognostic value and characteristics of the disease recurrence pattern for each INF type were assessed in 785 patients with various stages of GC and also in 243 patients with stages 2 and 3 GC.
RESULTS: Comparison of the overall survival experienced by patients independently of stage showed that INF was significantly associated with prognosis. Specifically, peritoneal metastasis was present in 91 % of stage 4 patients in the INFc group, whereas hepatic metastasis was present in 39 % of stage 4 patients in the INFa and INFb group. After curative gastrectomy of patients with stages 2 or 3 GC, INF was not significantly associated with survival. The prevalence of peritoneal recurrence was significantly higher in the INFc group than in the INFa and INFb group, whereas the prevalence of hepatic recurrence was significantly higher in the INFa and INFb group than in the INFc group. Multivariate analysis identified INFc as an independent risk factor for peritoneal recurrence after curative gastrectomy. The association of the INF type with the incidence of peritoneal recurrence was observed with all disease stages regardless whether the patient was given adjuvant chemotherapy or not.
CONCLUSIONS: Evaluation of the INF type shows promise for its role as a predictor of postoperative recurrence sites in patients with GC.

Entities:  

Mesh:

Year:  2016        PMID: 26847679     DOI: 10.1245/s10434-016-5102-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer.

Authors:  Yuri Tanaka; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Akira Mizuno; Naoki Iwata; Masamichi Hayashi; Yukiko Niwa; Hideki Takami; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2016-10-12       Impact factor: 7.370

2.  Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis.

Authors:  Akimitsu Iizuka; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

3.  Preoperative Albumin-Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer.

Authors:  Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Hiroaki Uda; Kenichi Inaoka; Yuri Tanaka; Masamichi Hayashi; Naoki Iwata; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy.

Authors:  Bin Sato; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Naoki Iwata; Norifumi Hattori; Masaya Suenaga; Masamichi Hayashi; Suguru Yamada; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 5.  Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery.

Authors:  Biying Huang; Ioannis Rouvelas; Magnus Nilsson
Journal:  Ann Gastroenterol Surg       Date:  2022-03-24

Review 6.  Molecular mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

7.  Inhibition of circRNA circVPS33B Reduces Warburg Effect and Tumor Growth Through Regulating the miR-873-5p/HNRNPK Axis in Infiltrative Gastric Cancer.

Authors:  Yizhuo Lu; Jia Cheng; Wangyu Cai; Huiqin Zhuo; Guoyang Wu; Jianchun Cai
Journal:  Onco Targets Ther       Date:  2021-05-12       Impact factor: 4.147

8.  Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer.

Authors:  Kenichi Inaoka; Mitsuro Kanda; Hiroaki Uda; Yuri Tanaka; Chie Tanaka; Daisuke Kobayashi; Hideki Takami; Naoki Iwata; Masamichi Hayashi; Yukiko Niwa; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

9.  GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Haruyoshi Tanaka; Daisuke Kobayashi; Chie Tanaka; Masamichi Hayashi; Naoki Iwata; Yukiko Niwa; Hideki Takami; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

10.  Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer.

Authors:  Mitsuro Kanda; Akira Mizuno; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Naoki Iwata; Masamichi Hayashi; Suguru Yamada; Goro Nakayama; Tsutomu Fujii; Hiroyuki Sugimoto; Masahiko Koike; Hideki Takami; Yukiko Niwa; Kenta Murotani; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.